Clinical Trials · NCT07071974
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 16
- Start date
- Jul 2025
- Locations
- 1 site, Germany
- Primary endpoint
- AUC0-tz (area under the concentration-time curve of the analyte in plasma over the time interval from 0 to the last quantifiable data point)